Spectrum Pharma Inc (SPPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -158,628 | -118,913 | -85,829 | -35,697 | -160,868 |
| Depreciation Amortization | 679 | 212 | 138 | 65 | 261 |
| Accounts receivable | 1,510 | -1,325 | -995 | -324 | 7,165 |
| Other Working Capital | 2,647 | 4,151 | 3,758 | -5,683 | -12,529 |
| Other Operating Activity | 34,306 | 26,736 | 18,787 | 7,148 | 44,342 |
| Operating Cash Flow | $-119,486 | $-89,139 | $-64,141 | $-34,491 | $-121,629 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -16,568 | 75,672 | 33,859 | 19,653 |
| PPE Investments | -221 | 109,631 | 3,922 | -73 | -5,535 |
| Purchase Of Investment | 108,932 | N/A | N/A | N/A | N/A |
| Sale Of Investment | N/A | 4,406 | N/A | 2,858 | 3,954 |
| Investing Cash Flow | $108,711 | $97,469 | $79,594 | $36,644 | $18,072 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 53,306 | 53,100 | 53,098 | 21,357 | 85,230 |
| Other Financing Activity | 4 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $53,310 | $53,100 | $53,098 | $21,357 | $85,230 |
| Exchange Rate Effect | -5 | -4 | 13 | 2 | -82 |
| Beginning Cash Position | 46,009 | 46,009 | 46,009 | 46,009 | 64,418 |
| End Cash Position | 88,539 | 107,435 | 114,573 | 69,521 | 46,009 |
| Net Cash Flow | $42,530 | $61,426 | $68,564 | $23,512 | $-18,409 |
| Free Cash Flow | |||||
| Operating Cash Flow | -119,486 | -89,139 | -64,141 | -34,491 | -121,629 |
| Capital Expenditure | -221 | -140 | -140 | -73 | -5,535 |
| Free Cash Flow | -119,707 | -89,279 | -64,281 | -34,564 | -127,164 |